Race may account for the disparity in pharmacological treatment of insomnia

In one of the first studies to investigate racial disparities in the pharmacologic treatment of insomnia, researchers from Regenstrief Institute and Indiana University report that patients belonging to racial minority groups were significantly less likely to be prescribed medication following diagnosis of insomnia than White patients.

Related Keywords

Bloomington ,Indiana ,United States ,Indiana University ,Lily Ramsey ,Malaz Boustani ,Indiana University School Of Public Health Bloomington ,Indiana Health Information Exchange ,Regenstrief Institute Research Scientist Arthur Owora ,Us Centers For Disease ,Regenstrief Institute Research Scientist Noll Campbell ,Regenstrief Research Scientist ,Regenstrief Institute Research Scientist Paul Dexter ,Regenstrief Institute ,Indiana Network For Patient Care ,Regenstrief Research ,Disease Control ,Indiana Network ,Patient Care ,Indiana Health Information ,Emma Holler ,Indiana University School ,